Camena Bioscience Limited

Active09955243 Private limited company

Incorporated: 18 January 2016 (10 years)
Previously known as: Dna Write Limited (until 11 October 2017)
This list may be incomplete. See all names on Companies House
Industry: Research and experimental development on biotechnology (72110)
Directors: Gregory Paul Mcguinness
Mercia Fund Management (Nominees) Limited
Philip Charles Nelson
all 6 directors
Accounts type: Small
Region: East of England
Address: Sidney Sussex Chesterford Park
Little Chesterford
Saffron Walden
CB10 1XL

Filing status

Accounts due: 31 October 2027
Last accounts: 31 January 2026
Conf. stmt due: 4 July 2027
Last conf. stmt: 20 June 2026

Charges

Total: 1
Outstanding: 0
Part satisfied: 0
Satisfied: 1

Officers 6 active

Officer details are public data from the Companies House register.

Mcguinness, Gregory Paul

Director · Appointed 1 July 2026

Irish

Born April 1964 (62)

Mercia Fund Management (Nominees) Limited

Corporate Director · Appointed 17 September 2025

Also at Napo Limited, Iventis Ltd, Alertive Limited · more companies

Nelson, Philip Charles

Director · Appointed 4 September 2025

American

Born February 1963 (63)

Rajagopal, Aditya, Dr

Director · Appointed 15 June 2023

American

Born July 1986 (40)

Mahanthappa, Nagesh, Dr

Director · Appointed 17 November 2016

American

Born September 1964 (62)

Harvey, Steven Andrew, Dr

Director · Appointed 18 January 2016

British

Born October 1980 (46)

Officer history (5 former)

1 July 2026

Appointed Mcguinness, Gregory Paul as Director

17 September 2025

Appointed Mercia Fund Management (Nominees) Limited as Corporate Director

17 September 2025

Resigned Lindley, Lee James as Director

4 September 2025

Appointed Nelson, Philip Charles as Director

21 February 2025

Resigned Thompson, Nicola, Dr as Director

20 November 2023

Appointed Thompson, Nicola, Dr as Director

15 June 2023

Appointed Rajagopal, Aditya, Dr as Director

28 April 2023

Resigned Stemple, Derek as Director

28 April 2023

Appointed Lindley, Lee James as Director

28 April 2023

Resigned Fraser, Scott, Dr as Director

21 November 2022

Resigned Burke, Julian Francis as Director

24 March 2021

Appointed Fraser, Scott, Dr as Director

4 March 2021

Appointed Burke, Julian Francis as Director

17 November 2016

Appointed Mahanthappa, Nagesh, Dr as Director

1 March 2016

Appointed Stemple, Derek as Director

18 January 2016

Appointed Harvey, Steven Andrew, Dr as Director

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.

Former controllers (4)

9 February 2023

Ceased Steven Andrew Harvey — Has significant influence or control

9 February 2023

Ceased Scott Fraser — Has significant influence or control

9 February 2023

Ceased Derek Stemple — Has significant influence or control

9 February 2023

Ceased Andrew Fraser — Has significant influence or control

Financials

Figures from 2023 accounts. Newer accounts, made up to 31 January 2026, are filed but not read yet. See them on Companies House

Net Assets: (£2,535,903); down £1,798,574 (244%)
Cash: £2,286,034; up £1,644,200 (256%)
Employees: 7; up 3 (75%)

Debt Ratio: 192%
Current Ratio: 0.5x

Trend

Net Assets

Balance sheet detail

	2023	2022	2021	2020
Fixed Assets	£200,016	£217,381	£21,036
Current Assets	£2,546,175	£1,408,728	£643,808	£398,729
Debtors			£556,587	£371,503
Cash	£2,286,034	£641,834	£87,221	£27,226
Creditors (< 1 year)	£5,282,094	£2,363,438	£517,358	£176,720
Net Current Assets	(£2,735,919)	(£954,710)	£126,450	£222,009
Net Assets	(£2,535,903)	(£737,329)	£147,486	£274,730
Shareholder Funds	(£2,535,903)	(£737,329)	£147,486	£274,730